Sodium Zirconium Cyclosilicate
Red
Brand:
Lokelma
Nice TA:
599
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Blood and Nutrition
Background
1.1 Sodium zirconium cyclosilicate is recommended as an option for treating hyperkalaemia in adults only if used:
-
in emergency care for acute life-threatening hyperkalaemia alongside standard care or
-
for people with persistent hyperkalaemia and chronic kidney disease stage 3b to 5 or heart failure, if they:
-
have a confirmed serum potassium level of at least 6.0 mmol/litre and
-
because of hyperkalaemia, are not taking an optimised dosage of renin-angiotensin-aldosterone system (RAAS) inhibitor and
-
are not on dialysis. [amended 2022]
-